Document ID: chunk:federal_register_of_legislation:F2025C00214:clause:1_61109:p2
Version: federal_register_of_legislation:F2025C00214
Segment Type: clause
Provision Reference: sch 1 cl 61109 (pt 2/4)
Character Range: 255990–259140

clinical indications apply to the patient:
 (a) the patient does not have a known coronary artery disease but assessment indicates that resting twelve‑lead electrocardiogram changes are consistent with coronary artery disease or ischaemia;
 (b) coronary artery disease related lesions, of uncertain functional significance, have previously been identified on a computed tomography coronary angiography or invasive coronary angiography;
 (c) an assessment by a specialist or consultant physician indicates that the patient has possible painless myocardial ischaemia, where a stress myocardial perfusion study is likely to assist the diagnosis;
 (d) an assessment indicates that the patient has undue exertional dyspnoea of uncertain aetiology;
 (e) a pre‑operative assessment of the patient, who has a functional capacity of less than 4 metabolic equivalents, confirms that surgery is an intermediate to high risk, and the patient also has at least one of the following conditions:
 (i) ischaemic heart disease;
 (ii) previous myocardial infarction;
 (iii) heart failure;
 (iv) stroke;
 (v) transient ischaemic attack;
 (vi) renal dysfunction (serum creatinine greater than 170umol/L or 2 mg/dL or a creatinine clearance of less than 60 mL/min);
 (vii) diabetes mellitus requiring insulin therapy;
 (f) assessment, including quantification, is required before either percutaneous coronary intervention or coronary bypass surgery to quantify the extent and severity of myocardial ischaemia, and to ensure the criteria for intervention are met;
 (g) assessment is required of relative amounts of ischaemic viable myocardium and non‑viable (infarcted) myocardium because the patient has a previous myocardial infarction;
 (h) assessment of myocardial ischaemia with exercise is required because the patient has congenital heart lesions, has undergone surgery and ischemia is considered possible;
 (i) the patient is under 17 years old, with coronary anomalies, and assessment of myocardial perfusion is required before and after cardiac surgery:
 (i) for congenital heart disease; or
 (ii) where there is a probable or confirmed coronary artery abnormality;
 (j) myocardial perfusion abnormality is suspected but, due to the patient's cognitive capacity or expressive language impairment, it is not possible to accurately assess symptom frequency based on medical history.

2.4.1C  Stress myocardial perfusion studies—requirements
 (1) A stress myocardial perfusion study must be performed:
 (a) on premises equipped with resuscitation equipment, including a defibrillator; and
 (b) by a person trained in cardiopulmonary resuscitation who is in continuous personal attendance during the procedure.
 (2) At the time the service is performed, a second person trained in the matters mentioned in subclause (4) and cardiopulmonary resuscitation must be located at the premises while the exercise test is performed, and must be immediately available to respond if required.
 (3) One of the persons mentioned in subclauses (1) and (2) must be a medical practitioner.
 (4) For the purposes of subclause (2), the matters are:
 (a) how to safely perform exercise